Skip to content
Global Cause Global Cause
  • AMR & Infectious Diseases
  • Global Health Resilience
  • Empowering Women & Girls
  • Climate Action
  • Antimicrobial Resistance
  • Infectious Diseases
  • Global Resilience

Clinical Trials Q1 2021

  • s Sponsored

    Improving outcomes for neurology clinical trials

    Clinical trials in neurological diseases are a complex area of research where figures suggest there is an unusually high failure rate. Data from the United States shows that only 5.9% of phase I neurology clinical trial drugs are likely to get FDA approval and of the 2,352 neurology clinical trials started in 2020, fewer than...

    2 min read
  • Re-evaluating clinical trials to ensure their effective progress

    Strengthening clinical trial capabilities and infrastructure is key to yielding actionable data.  The COVID-19 pandemic has posed challenges to the conduct of all clinical trials, including those for COVID-19. To advise investigators during the pandemic, the Food and Drug Administration (FDA) issued guidance on how best to adapt trials, including recommendations on the use of virtual visits and methods for secure delivery of medications.   The agency also issued guidance...

    2 min read

Footer

Our campaigns

About Global Cause

About Mediaplanet

Privacy statement

Contact us

Back to top

© 2026 Mediaplanet Group
Privacy Policy | Revise privacy settings